Summary#
This bill would stop federal money from being used for research or publications about gender transition in people under 18. It specifically bars federally funded studies (including observational studies) that gather evidence on hormonal treatments or surgeries for minors when the purpose is to affirm a minor’s perception of their sex or an asserted identity that differs from their sex at birth. The bill also defines “sex” as a person’s reproductive biology and genetics at birth.
- Main change: Federal funds could not be used for research or publications whose purpose is to affirm a minor’s gender perception or asserted identity that is different from sex at birth.
- Scope shown in the text: Includes observational studies that collect evidence about hormonal or surgical treatments for minors.
- New definition: “Sex” is defined solely by reproductive biology and genetics at birth.
- What is unclear: The bill does not say how agencies will decide whether a study’s purpose is “to affirm” identity, which kinds of federal funding (grants, contracts, fellowships) are covered in detail, or how the rule applies to basic research, data analysis, or multi‑center studies.
What it means for you#
- Researchers and universities: Federal agencies that fund research (for example through grants or contracts) could not support studies or funded publications that the agency determines are aimed at affirming a minor’s gender perception or identity that differs from sex at birth. This could limit projects that collect data on medical or mental‑health outcomes of transition‑related care for minors.
- Medical providers and hospitals: The bill does not directly ban clinical care or treatments. However, it could reduce federally funded research that informs best practices for treating minors, which could affect clinical guidance over time.
- Federal agencies: Agencies that distribute research funds would need to interpret and apply the ban. They would decide which proposals and publications fall under the prohibition.
- Publishers and journals: If a publication resulted from federally funded work that an agency views as prohibited, funding for that publication could be at risk. The bill does not clearly say how publication funding is defined or enforced.
- Minors and families: The bill does not by its text stop parents or doctors from seeking or providing care. But it could reduce the amount of federally supported research about outcomes of transition‑related treatments for minors.
- Clinical and public‑health evidence: This could mean fewer federally funded studies on the short‑ and long‑term effects of hormonal or surgical treatments in people under 18. That would likely affect the available evidence base for policy and care decisions.
Expenses#
No publicly available information.
- The bill text and provided summary do not include a fiscal note, budget estimate, or estimates of administrative costs.
- It is not specified whether agencies would need new staff, review systems, or legal resources to implement and enforce the prohibition.
- It is not specified whether any existing grants would be terminated or reprogrammed, or whether there would be legal or contract costs.
Proponents' View#
- The bill appears intended to stop federal funding for research or publications that the bill’s drafters consider to promote or affirm gender transition in minors.
- A possible argument for the bill is that taxpayer funds should not be used for studies that the sponsor believes affirm a minor’s gender perception or identity when that differs from sex at birth.
- The title of the bill and its language suggest the goal is to protect minors by limiting federal support for research the sponsors view as “harmful.”
Opponents' View#
- One concern is that the language is vague about what counts as research “for the purpose of affirming” identity. That vagueness could make agencies or researchers avoid studying related topics to reduce legal or funding risk (a “chilling effect”).
- The bill does not clearly say which types of federal funding are covered (grants, contracts, cooperative agreements, fellowships, subawards), so implementation could be inconsistent.
- The restriction could reduce the evidence available about medical and mental‑health outcomes for minors who receive or consider transition‑related care. This may make it harder for clinicians and families to get information about risks and benefits.
- It is unclear how the birth‑based definition of “sex” applies to intersex individuals or to records where genetic or reproductive biology at birth is not documented.
- The bill provides no enforcement rules, transition plan, or exceptions for basic scientific research, public‑health surveillance, or research designed to study harms or benefits objectively.